CaMKII, endocannabinoids, synaptic plasticity and motor function
CaMKII、内源性大麻素、突触可塑性和运动功能
基本信息
- 批准号:8438247
- 负责人:
- 金额:$ 34.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-09-01 至 2017-06-30
- 项目状态:已结题
- 来源:
- 关键词:2-arachidonylglycerolAtaxiaBasal GangliaBehaviorBindingBiological AssayBrainBrain regionCellsCerebellumComplexCorpus striatum structureDepressed moodDopamineDopamine D2 ReceptorEndocannabinoidsEnzymesEquilibriumExcitatory SynapseExhibitsFollow-Up StudiesFunctional disorderGlutamatesGlycerolGoalsHippocampus (Brain)Home environmentHuntington DiseaseHyperactive behaviorKnock-in MouseLearningLeftLinkMemoryMental DepressionMetabolismMolecularMonitorMotorMotor ActivityMotor CortexMovementMovement DisordersMusMutant Strains MiceMutationNeuronsOutputParkinson DiseasePathway interactionsPeptidesPhosphorylationPhosphorylation SitePhysiologicalPlayPropertyProteinsRegulationReporterRoleSignal TransductionSiteSliceSynapsesSynaptic plasticityTestingThalamic structureTracerTransgenic Organismsbasecalmodulin-dependent protein kinase IIcell typegamma-Aminobutyric Acidin vivoinhibitor/antagonistlipoprotein lipasemotor deficitmotor learningnervous system disordernew therapeutic targetnovelpostsynapticselective expressionsynaptic depressionsynaptic functiontool
项目摘要
DESCRIPTION (provided by applicant): The striatum plays a key role in motor activity/coordination and goal-directed, habitual learning. Normal striatal drive of motor activity
requires precisely balanced opposing outputs from two types of striatal medium spiny neurons (MSNs) that express D1- and D2-dopamine(DA) receptors. A complex signaling cross-talk between glutamate and DA in D1- and D2-MSNs involves "on demand" Ca2+-dependent endocannabinoid (eCB) synthesis. Thus, DA, glutamate and eCBs collaborate to balance short- and long-term control of the two striatal output pathways by engaging distinct signaling mechanisms in the two MSN subtypes. Disruption of these mechanisms can induce motor deficits (e.g., Parkinson's Disease) or other abnormal striatal-based behaviors. Ca2+/calmodulin-dependent protein kinase II (CaMKII) has diverse bidirectional roles controlling excitatory synapses in hippocampus, cortex and cerebellum. While CaMKII is expressed in both striatal MSN subtypes, suggesting that it regulates excitatory inputs to striatal MSNs and motor activity, the precise functions of striatal CaMKII are poorly understood. Our analyses of knockin mutant mice with the Thr286 autophosphorylation site in CaMKII? replaced by Ala (T286A-KI mice) revealed specific roles for CaMKII in long- and short term eCB- dependent control of excitatory inputs to D1- and D2-MSNs. We also found that CaMKII? associates with and phosphorylates diacylglycerol lipase ? (DGL?), the rate-limiting enzyme for Ca2+-dependent synthesis of the most abundant brain eCB, 2-arachidonyl glycerol (2-AG). In addition, baseline hyperactivity of T286A-KI mice can be rescued by inhibiting 2-AG breakdown. These initial findings strongly support a novel hypothesis that CaMKII is a critical link between postsynaptic Ca2+ and the initiation of 2-AG signaling that controls striatal synapses and striatal based-behaviors. We also created novel transgenic eAC3I mice that selectively express a short CaMKII inhibitor peptide fused to eGFP in striatal MSNs. Three specific aims will exploit unique features of T286A-KI and eAC3I mice to test specific hypotheses about the roles of striatal CaMKII autophosphorylation and activity. 1. Test the hypothesis that Ca2+-dependent 2-AG synthesis is modulated by CaMKII. We will identify sites of phosphorylation and CaMKII-binding domains in DGL?. DGL? phosphorylation, DGL? activity and 2-AG synthesis will be investigated in heterologous cells and in striatal slices from WT, T286A-KI and eAC3I mice. 2. Test the hypothesis that CaMKII modulates eCB-dependent synaptic regulation in striatal MSNs. Short and long-term roles of CaMKII will be determined by comparing the properties of excitatory synaptic inputs to D1- and D2-MSNs in striatal slices from WT, T286A-KI and eAC3I mice, and by using CaMKII inhibitor peptides. 3. Test the hypothesis that CaMKII modulates eCB-dependent motor activity. We will evaluate motor activity and coordination under basal conditions and following pharmacological modulation of 2-AG metabolism in WT, T286A-KI and eAC3I mice.
PUBLIC HEALTH RELEVANCE: Normal movement and coordination is dependent on a brain region called the striatum, and damage to the striatum gives rise to movement disorders such as Parkinson's Disease, Huntington's Disease and several forms of ataxia. The principle neuronal cells in striatum (medium spiny neurons) integrate input signals from motor cortex and thalamus to provide precisely balanced output to other brain regions that control motor activity. This project investigates molecular mechanisms that control the strength of these input signals, with the goal of identifying novel therapeutic targets to treat movement disorders.
描述(由申请人提供):纹状体在运动活动/协调和目标导向的习惯性学习中起关键作用。正常纹状体运动驱动
需要精确平衡来自表达D1-和D2-多巴胺(DA)受体的两种类型的纹状体中型多刺神经元(MSN)的相反输出。在D1-和D2-MSN中谷氨酸和DA之间的复杂信号传导串扰涉及“按需”Ca 2+依赖性内源性大麻素(eCB)合成。因此,DA,谷氨酸和eCB合作,以平衡短期和长期控制的两个纹状体输出途径,通过从事不同的信号传导机制在两个MSN亚型。这些机制的破坏可以诱导运动缺陷(例如,帕金森氏病)或其他异常的基于纹状体的行为。Ca 2 +/钙调素依赖性蛋白激酶II(CaMKII)在海马、皮质和小脑中具有多种双向作用,控制兴奋性突触。虽然CaMKII在两种纹状体MSN亚型中表达,表明它调节纹状体MSN和运动活动的兴奋性输入,但纹状体CaMKII的确切功能知之甚少。我们的分析敲入突变小鼠与Thr 286自磷酸化位点的CaMK Ⅱ?用Ala替代的小鼠(T286 A-KI小鼠)的研究揭示了CaMK II在对D1-和D2-MSN的兴奋性输入的长期和短期eCB依赖性控制中的特定作用。我们还发现CaMKII?与二酰基甘油脂肪酶结合并磷酸化二酰基甘油脂肪酶?(DGL?),最丰富的脑eCB的Ca 2+依赖性合成的限速酶,2-花生四烯酸甘油(2-AG)。此外,T286 A-KI小鼠的基线活动过度可以通过抑制2-AG分解来挽救。这些初步的研究结果有力地支持了一个新的假设,即CaMKII是突触后Ca 2+和2-AG信号的启动之间的关键环节,控制纹状体突触和纹状体为基础的行为。我们还创建了新型转基因eAC 3 I小鼠,其选择性地表达与纹状体MSN中的eGFP融合的短CaMKII抑制剂肽。三个具体的目标将利用T286 A-KI和eAC 3 I小鼠的独特功能来测试关于纹状体CaMKII自磷酸化和活性的作用的具体假设。1.检验Ca 2+依赖性2-AG合成受CaMKII调节的假设。我们将鉴定DGL?中的磷酸化位点和CaMKII结合结构域。DGL?磷酸化,DGL?将在异源细胞和来自WT、T286 A-KI和eAC 3 I小鼠的纹状体切片中研究活性和2-AG合成。2.检验CaMKII调节纹状体MSNs中eCB依赖性突触调节的假设。通过比较WT、T286 A-KI和eAC 3 I小鼠纹状体切片中D1-和D2-MSN的兴奋性突触输入的性质,并通过使用CaMKII抑制剂肽,确定CaMKII的短期和长期作用。3.检验CaMKII调节eCB依赖性运动活动的假设。我们将在WT、T286 A-KI和eAC 3 I小鼠中评价基础条件下和2-AG代谢药理学调节后的运动活性和协调性。
公共卫生关系:正常的运动和协调依赖于称为纹状体的大脑区域,并且纹状体的损伤引起运动障碍,例如帕金森病、亨廷顿病和几种形式的共济失调。纹状体中的主要神经元细胞(中等多刺神经元)整合来自运动皮层和丘脑的输入信号,为控制运动活动的其他大脑区域提供精确平衡的输出。该项目研究控制这些输入信号强度的分子机制,目的是确定治疗运动障碍的新治疗靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROGER J COLBRAN其他文献
ROGER J COLBRAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROGER J COLBRAN', 18)}}的其他基金
Molecular Neuropharmacology and Signaling of Histone H2A.Z
组蛋白 H2A.Z 的分子神经药理学和信号转导
- 批准号:
9626431 - 财政年份:2017
- 资助金额:
$ 34.6万 - 项目类别:
Molecular Neuropharmacology and Signaling of Histone H2A.Z
组蛋白 H2A.Z 的分子神经药理学和信号转导
- 批准号:
9480880 - 财政年份:2017
- 资助金额:
$ 34.6万 - 项目类别:
Molecular Neuropharmacology and Signaling of Histone H2A.Z
组蛋白 H2A.Z 的分子神经药理学和信号转导
- 批准号:
10115117 - 财政年份:2017
- 资助金额:
$ 34.6万 - 项目类别:
Postdoctoral Program in Functional Neurogenomics
功能神经基因组学博士后项目
- 批准号:
9386221 - 财政年份:2016
- 资助金额:
$ 34.6万 - 项目类别:
CaMKII, endocannabinoids, synaptic plasticity and motor function
CaMKII、内源性大麻素、突触可塑性和运动功能
- 批准号:
8536971 - 财政年份:2012
- 资助金额:
$ 34.6万 - 项目类别:
CaMKII, endocannabinoids, synaptic plasticity and motor function
CaMKII、内源性大麻素、突触可塑性和运动功能
- 批准号:
8885927 - 财政年份:2012
- 资助金额:
$ 34.6万 - 项目类别:
CaMKII, endocannabinoids, synaptic plasticity and motor function
CaMKII、内源性大麻素、突触可塑性和运动功能
- 批准号:
8697154 - 财政年份:2012
- 资助金额:
$ 34.6万 - 项目类别:
CaMKII, endocannabinoids, synaptic plasticity and motor function
CaMKII、内源性大麻素、突触可塑性和运动功能
- 批准号:
9102281 - 财政年份:2012
- 资助金额:
$ 34.6万 - 项目类别:
Postdoctoral Program in Functional Neurogenomics
功能神经基因组学博士后项目
- 批准号:
9925810 - 财政年份:2002
- 资助金额:
$ 34.6万 - 项目类别:
Postdoctoral Program in Functional Neurogenomics
功能神经基因组学博士后项目
- 批准号:
9096901 - 财政年份:2002
- 资助金额:
$ 34.6万 - 项目类别:
相似海外基金
How exercise improves ataxia in SCA6
运动如何改善 SCA6 的共济失调
- 批准号:
479005 - 财政年份:2023
- 资助金额:
$ 34.6万 - 项目类别:
Operating Grants
Exploratoin of Nrf2 activators that potentiate chaperone-mediated autophagy and are useful for the treatment of spinocrebellar ataxia
探索增强伴侣介导的自噬并可用于治疗脊髓小脑共济失调的 Nrf2 激活剂
- 批准号:
23K06161 - 财政年份:2023
- 资助金额:
$ 34.6万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Defining the role of Tox3 in congenital cerebellar hypoplasia and ataxia
定义 Tox3 在先天性小脑发育不全和共济失调中的作用
- 批准号:
10799992 - 财政年份:2023
- 资助金额:
$ 34.6万 - 项目类别:
Genome-wide dysregulation of R-loops in Ataxia Telangiectasia neurological pathogenesis
共济失调毛细血管扩张症神经发病机制中 R 环的全基因组失调
- 批准号:
10607414 - 财政年份:2023
- 资助金额:
$ 34.6万 - 项目类别:
Identifying the molecular mechanisms of GEMIN5 mutations in a novel cerebellar ataxia syndrome
鉴定新型小脑共济失调综合征中 GEMIN5 突变的分子机制
- 批准号:
10753403 - 财政年份:2023
- 资助金额:
$ 34.6万 - 项目类别:
Project 2: Therapeutic Gene Editing for Friedreich's Ataxia
项目 2:弗里德赖希共济失调的治疗性基因编辑
- 批准号:
10668768 - 财政年份:2023
- 资助金额:
$ 34.6万 - 项目类别:
The Impact of Vitamin D on mTOR Signaling, Seizures, and Motor Behavior in a Mouse Model of Hyperactive mTOR Induced Epilepsy and Ataxia
维生素 D 对 mTOR 过度活跃诱发癫痫和共济失调小鼠模型中 mTOR 信号传导、癫痫发作和运动行为的影响
- 批准号:
10754319 - 财政年份:2023
- 资助金额:
$ 34.6万 - 项目类别:
Pathological Mechanisms of Immune-Mediated Cerebellar Ataxia with Associated Sez6L2 Autoantibodies
免疫介导的小脑共济失调与相关 Sez6L2 自身抗体的病理机制
- 批准号:
10740682 - 财政年份:2023
- 资助金额:
$ 34.6万 - 项目类别:
Molecular Pathogenesis of spinocerebellar ataxia type 12
12 型脊髓小脑共济失调的分子发病机制
- 批准号:
10579736 - 财政年份:2023
- 资助金额:
$ 34.6万 - 项目类别: